Exploring the role of the IGF and insulin systems in health and disease
Official title: 2025 IGF and Insulin System in Physiology and Disease Gordon Research Conference and Gordon Research Seminar
Funded at Gordon Research Conferences · NIH-11065205 · Data updated 2026-11-12
This conference is for scientists and researchers to talk about how a system in our bodies called the IGF axis affects growth, aging, and metabolism, and how problems with it can lead to diseases like cancer and diabetes, while also sharing the latest findings and connecting with each other for future research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gordon Research Conferences NIH-funded |
| Lab location | 1 site (East Greenwich, UNITED STATES) |
| Project start | January 1, 2025 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $10,000 |
| NIH project number | 1R13DK142231-01 |
| Project ID | NIH-11065205 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by conditions such as cancer, diabetes, and cardiovascular diseases.
✕Less likely to help
Patients who do not have any of the conditions related to IGF and insulin dysregulation may not receive direct benefits from this research.
What this research studies
This conference brings together leading scientists and emerging scholars to discuss the Insulin-like Growth Factor (IGF) axis, which is crucial for development, aging, and metabolism. Participants will explore how dysregulation of this system is linked to diseases such as cancer, diabetes, and cardiovascular conditions. The conference will feature discussions on the dual nature of IGF-1, its roles in inflammation and metabolism, and the latest research on its impact on health span. Attendees will have opportunities for mentorship and networking, fostering collaboration among researchers from around the world.
Why it matters
Potential benefit: If successful, this research could lead to new insights and interventions for diseases related to the IGF and insulin systems, potentially improving patient outcomes.
How similar studies have gone: Previous Gordon Research Conferences have successfully advanced understanding in various biomedical fields, indicating a strong potential for impactful outcomes in this area as well.
Where this research is happening
-
Gordon Research Conferences
East Greenwich, United States Active
Researchers
- Principal investigator: Yakar, Shoshana — Gordon Research Conferences
- Study coordinator: Yakar, Shoshana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.